Creators

Falsified medicines directive – it is now or never for pharmaceutical companies

EFPIA’s Christoph Krähenbühl provides an overview of the requirements of the legislation, how these will impact on companies and what it means in practical terms The third report from the seminars at the Total Processing & Packaging Exhibition     Christoph started by outlining the growing and substantial threat of falsified medicines penetrating the European pharmaceutical